1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Enfermedades Infecciosas

Enfermedades Infecciosas

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Varela Barca L, Navas Elorza E, Fernández-Hidalgo N, Moya Mur JL, Muriel García A, Fernández-Felix BM, Miguelena Hycka J, Rodríguez-Roda J, López-Menéndez J.

    Correction to: Prognostic factors of mortality after surgery in infective endocarditis: systematic review and meta-analysis.

    Infection . 47(6): 897-897. Nº de citas: 1

    [doi:10.1007/s15010-019-01357-8]

  • Sainz T, Serrano-Villar S, Mann S, Ma ZM, Utay NS, Thompson CG, Chun TW, Kashuba AD, Siewe B, Albanese A, Troia-Cancio P, Sinclair E, Somasunderam A, Yotter T, Moreno S, Pollard RB, Landay A, Miller CJ, Asmuth DM.

    Delayed GALT reconstitution in duodenum compared to rectum in hiv-infected patients initiating antiretroviral therapy.

    AIDS . 33(15): 2289-2298. Nº de citas: 4

    [doi:10.1097/QAD.0000000000002361]

  • Varela Barca L, Navas Elorza E, Fernéndez-Hidalgo N, Moya Mur JL, Muriel García A, Fernández-Felix BM, Miguelena Hycka J, Rodríguez-Roda J, López-Menéndez J.

    Prognostic factors of mortality after surgery in infective endocarditis: systematic review and meta-analysis.

    Infection . 47(6): 879-895. Nº de citas: 11

    [doi:10.1007/s15010-019-01338-x]

  • García LM, Iniesta C, Garrido J, Fuster MJ, Pujol F, Meulbroek M, Poveda T, Riera M, Antela A, Moreno S, Dalmau D, Rivero A, García D, Espacio R, Del Amo J.

    HIV pre-exposure prophylaxis (PrEP) in Spain: political and administrative situation.

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 37(10): 656-660. Nº de citas: 4

    [doi:10.1016/j.eimc.2018.05.012]

  • Gorospe L, Casado JL, Serrano-Villar S, de la Puente-Bujidos C, Pérez-Elías MJ, Vivancos-Gallego MJ.

    Atraumatic Incomplete Sternal Fracture Incidentally Detected in a Human Immunodeficiency Virus Patient at Lung Cancer Screening With Low-Dose Thoracic CT.

    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY . 25(8): 132-132.

    [doi:10.1097/RHU.0000000000000790]

  • Serrano-Villar S, Estrada V.

    Reply to Taramasso et al.

    CLINICAL INFECTIOUS DISEASES . 69(12): 2229-2229.

    [doi:10.1093/cid/ciz341]

  • Lodi S, Günthard HF, Gill J, Phillips AN, Dunn D, Vu Q, Siemieniuk R, Garcia F, Logan R, Jose S, Bucher HC, Scherrer AU, Reiss P, van Sighem A, Boender TS, Porter K, Gilson R, Paraskevis D, Simeon M, Vourli G, Moreno S, Jarrin I, Sabin C, Hernán MA.

    Effectiveness of Transmitted Drug Resistance Testing Before Initiation of Antiretroviral Therapy in HIV-Positive Individuals.

    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES . 82(3): 314-320. Nº de citas: 5

    [doi:10.1097/QAI.0000000000002135]

  • Casado JL, Monsalvo M, Vizcarra P, Fontecha M, Serrano-Villar S, Moreno S.

    Evaluation of kidney function in HIV-infected patients receiving an antiretroviral regimen containing one or two inhibitors of the tubular secretion of creatinine.

    HIV MEDICINE . 20(10): 648-656. Nº de citas: 7

    [doi:10.1111/hiv.12784]

  • Neesgaard B, Pelchen-Matthews A, Ryom L, Florence E, Peters L, Roen A, Svedhem V, Clarke A, Benfield T, Mitsura V, Moreno S, Beniowski M, Begovac J, Matulionyte R, Trofimova T, Elbirt D, Kundro M, Vullo V, Behrens G, Staub T, Ragone L, Vannappagari V, Lundgren J, Mocroft A, EuroSIDA study.

    Uptake and effectiveness of two-drug compared to three-drug antiretroviral Regimens among HIV-positive Individuals in Europe.

    AIDS . 33(13): 2013-2024. Nº de citas: 11

    [doi:10.1097/QAD.0000000000002320]

  • Belén Pérez A, Chueca N, García-Deltoro M, Martínez-Sapiña AM, Lara-Pérez MM, García-Bujalance S, Aldámiz-Echevarría T, Vera-Méndez FJ, Antonio Pineda J, Casado M, Pascasio JM, Salmerón J, Alados-Arboledas JC, Poyato A, Téllez F, Rivero-Juárez A, Merino D, Vivancos-Gallego MJ, Rosales-Zábal JM, García F, GEHEP-004 Cohort.

    High efficacy of Resistance-guided retreatment of HCVpatients failing NS5A inhibitors in real world.

    JOURNAL OF HEPATOLOGY . 71(5): 876-888. Nº de citas: 9

    [doi:10.1016/j.jhep.2019.06.022]

  • Suárez-García I, González J, Berenguer J, García F, Portilla J, Muga R, Moreno S, Jarrín I.

    Reasons for noncompliance with the national guidelines for initial antiretroviral therapy of HIV-infected patients in Spain, 2010-2015.

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 37(9): 580-587. Nº de citas: 3

    [doi:10.1016/j.eimc.2019.02.007]

  • Gorospe Sarasúa L, Ureña-Vacas A, Arrieta P, Santos-Carreño AL, Navas-Elorza E, de la Puente-Bujidos C.

    Pulmonary sarcoidosis mimicking tuberculosis: Importance of the galaxy sign on thoracic computed tomography.

    REUMATOLOGIA CLINICA . 15(6): 133-135.

    [doi:10.1016/j.reuma.2017.07.022]

  • Pericàs JM, Llopis J, González-Ramallo V, Goenaga MÁ, Muñoz P, García-Leoni ME, Fariñas MC, Pajarón M, Ambrosioni J, Luque R, Goikoetxea J, Oteo JA, Carrizo E, Bodro M, Reguera-Iglesias JM, Navas E, Hidalgo-Tenorio C, Miró JM, GAMES investigators.

    Outpatient Parenteral Antibiotic Treatment (OPAT) for Infective Endocarditis: a Prospective Cohort Study From the GAMES Cohort.

    CLINICAL INFECTIOUS DISEASES . 69(10): 1690-1700. Nº de citas: 21

    [doi:10.1093/cid/ciz030]

  • Hidalgo-Tenorio C, Vinuesa D, Plata A, Martin Dávila P, Iftimie S, Sequera S, Loeches B, Lopez-Cortés LE, Fariñas MC, Fernández-Roldan C, Javier-Martinez R, Muñoz P, Arenas-Miras MDM, Martínez-Marcos FJ, Miró JM, Herrero C, Bereciartua E, De Jesus SE, Pasquau J.

    DALBACEN cohort: dalbavancin as consolidation therapy in patients with endocarditis and/or bloodstream infection produced by gram-positive cocci.

    ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS . 18(1): 30-30. Nº de citas: 38

    [doi:10.1186/s12941-019-0329-6]

  • Norman FF, López-Vélez R.

    Chagas Disease: Comments on the 2018 PAHO Guidelines for diagnosis and management.

    JOURNAL OF TRAVEL MEDICINE . 26(7): . Nº de citas: 11

    [doi:10.1093/jtm/taz060]

  • Rodríguez-Mora S, Spivak AM, Szaniawski MA, López-Huertas MR, Alcamí J, Planelles V, Coiras M.

    Tyrosine Kinase Inhibition: a New Perspective in the Fight against HIV.

    CURRENT HIV/AIDS REPORTS . 16(5): 414-422. Nº de citas: 3

    [doi:10.1007/s11904-019-00462-5]

  • Pérez Elías MJ, Alejos B, Vivancos MJ, Ribera E, Galindo MJ, Vilanova-Trillo L, García-Fraile Fraile LJ, de La Fuente Moral S, Garcia De Lomas J, Lozano F, Mateo García MG, Tasias Pitarch M, Diez Martinez M, Rojas J, Raya-Cruz M, Sepúlveda MA, Troya J, Del Campo S, Martinez E.

    Outcomes by sex following treatment initiation with darunavir/cobicistat in a large Spanish cohort of the CODAR study (GeSIDA 9316).

    The Journal of antimicrobial chemotherapy . 74(10): 3044-3048. Nº de citas: 2

    [doi:10.1093/jac/dkz254]

  • Valencia J, Alvaro-Meca A, Troya J, Cuevas G, Gutiérrez J, Morro A, Alvarez J, Pulido L, Cañamares I, Escobar I, Moreno S, Ryan P.

    High rates of early HCV reinfection after DAA treatment in people with recent drug use attended at mobile harm reduction units.

    INTERNATIONAL JOURNAL OF DRUG POLICY . 72: 181-188. Nº de citas: 13

    [doi:10.1016/j.drugpo.2019.06.016]